Saturday 17 October 2026
Export CTEV’s income statement to Excel — free account
Claritev Corporation
CTEV Healthcare Health Information Services
Claritev Corporation’s revenue for fiscal 2025 (year ended December 2025) was $965.4 million, up 3.74% from fiscal 2024. In the quarter to June 2026, revenue grew 6.59%, EPS grew 8.40%, free cash flow grew 49.1% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.
22.12
1.74
−7.29%
Follow CTEV
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 7 | 5 | 3 | 3 | 5 |
P/E ratio |
— | 972.00 | 972.00 | 0.00 | 27.69 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | 0.49 | 0.65 | 0.04 | 0.23 | (1.27) | (0.40) |
P/S ratio |
— | 0.00 | 0.00 | 4.01 | 2.58 | 0.62 | 0.92 | 0.26 | 0.73 |
Altman Z″-Score (non-manufacturers) |
— | — | 0.89 | 0.48 | 0.97 | 0.09 | 0.29 | (3.20) | (1.66) |
P/FCF ratio |
— | 0.00 | 0.00 | 12.27 | 9.01 | 2.35 | 14.06 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | (3.65) | (2.21) | (3.32) | (2.61) | (4.04) | (2.59) |
P/Operating CF |
— | 27.41 | 27.41 | 83.45 | 86.71 | 24.00 | 31.91 | (7.14) | 10.60 |
P/B ratio |
— | 3.78 | 3.78 | 1.47 | 1.23 | 0.37 | 0.52 | 2.84 | 0.00 |
Price to Tangible BV |
— | 3.78 | 3.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 0.00 | 0.00 | 8.77 | 6.79 | 4.70 | 5.56 | 5.08 | 5.46 |
EV/EBITDA |
— | 0.00 | 0.00 | 30.24 | 9.36 | 80.03 | 8.94 | 0.00 | 10.92 |
EV/Operating CF |
— | 0.00 | 0.00 | 21.78 | 18.75 | 13.64 | 31.15 | 43.97 | 44.91 |
EV/FCF |
— | 0.00 | 0.00 | 26.81 | 23.71 | 17.97 | 85.07 | (450.36) | (429.21) |
Quick Ratio |
— | — | 1.15 | 1.69 | 2.03 | 2.39 | 0.95 | 0.56 | 0.60 |
Current Ratio |
— | — | 1.35 | 1.86 | 2.25 | 2.54 | 1.16 | 0.82 | 0.86 |
Net Debt/EBITDA |
— | 0.00 | 7.02 | 16.40 | 5.80 | 69.56 | 7.46 | (4.77) | 9.46 |
Debt/Assets |
0.00% | 0.00% | 64.68% | 55.36% | 59.52% | 64.51% | 65.27% | 87.81% | 94.00% |
Debt/Equity |
— | 0.00 | 2.72 | 1.79 | 2.09 | 2.66 | 2.66 | 53.83 | (27.49) |
Asset Turnover |
— | 0.00 | 0.24 | 0.11 | 0.14 | 0.14 | 0.13 | 0.15 | 0.19 |
Operating CF/Net income |
— | 8.07 | 29.28 | (0.72) | 3.96 | (0.65) | (1.87) | (0.07) | (0.41) |
Capex/Depreciation |
— | (0.16) | (0.17) | (0.18) | (0.20) | (0.21) | (0.25) | (0.26) | (0.29) |
Interest Coverage |
— | 1.12 | 0.98 | (0.39) | 1.44 | (1.20) | 0.49 | (4.26) | 0.07 |
| — | 0.00% | 0.43% | (22.92%) | 4.16% | (27.71%) | (5.24%) | (183.57%) | 683.76% | |
| — | 0.00% | 0.23% | (6.26%) | 1.24% | (7.35%) | (1.28%) | (27.17%) | (5.66%) | |
ROIC |
— | 0.00% | 3.12% | (1.17%) | 3.42% | (3.65%) | 1.64% | (18.98%) | 0.41% |
Return on Tangible Assets |
— | 0.00% | 4.67% | (183.31%) | 26.14% | (113.73%) | (31.16%) | (647.01%) | (98.25%) |
Average Days of Receivables |
— | 0.00 | 28.62 | 24.60 | 32.63 | 26.67 | 29.06 | 35.20 | 48.25 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 7.45% | 7.65% | 37.92% | 13.52% | 15.45% | 14.89% | 16.21% | 22.95% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.96 | 0.95 | 0.93 | 0.90 | 0.93 | 0.90 | 0.88 |
Share Based Compensation of Revenue |
— | 0.45% | (1.51%) | 43.30% | 1.61% | 1.55% | 1.87% | 2.86% | 2.88% |
Graham Net Nets |
— | (0.01) | (0.01) | (1.47) | (1.93) | (7.73) | (5.73) | (20.49) | (6.88) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 144.03 | 0.00 | 0.00 | 0.00 | 62.92 |
Earnings Yield |
— | 0.10% | 0.10% | (13.83%) | 3.61% | (86.54%) | (10.93%) | (687.01%) | (40.47%) |
Free Cash Flow Yield |
— | 0.00% | 0.00% | 8.15% | 11.10% | 42.53% | 7.11% | (4.40%) | (1.75%) |
Revenue per Share |
— | 100.16 | 94.58 | 79.68 | 68.67 | 67.60 | 59.62 | 57.63 | 58.74 |
Operating CF per Share |
— | 28.13 | 27.36 | 32.06 | 24.87 | 23.31 | 10.65 | 6.66 | 7.14 |
Capex per Share |
— | (6.12) | (6.39) | (6.02) | (5.20) | (5.62) | (6.75) | (7.32) | (7.89) |
Free Cash Flow per Share |
— | 22.01 | 20.97 | 26.05 | 19.67 | 17.69 | 3.90 | (0.65) | (0.75) |
Cash per Share |
— | 0.00 | 2.10 | 10.77 | 11.57 | 21.32 | 5.05 | 1.84 | 1.72 |
Shareholders Equity per Share |
— | 0.00 | 191.02 | 217.33 | 144.06 | 112.10 | 105.97 | 5.20 | (10.17) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 191.02 | 217.33 | 144.06 | 112.10 | 105.97 | 5.20 | (10.17) |
Free Cash Flow |
— | 228.75 | 217.90 | 306.56 | 320.10 | 282.63 | 62.87 | (10.51) | (12.28) |
Working Capital |
— | — | 29.83 | 96.36 | 177.35 | 270.89 | 26.85 | (38.27) | (36.99) |
Capital Expenditures |
— | (63.56) | (66.41) | (70.81) | (84.59) | (89.73) | (108.85) | (118.12) | (129.60) |
Net Current Asset Value |
— | 0.00 | (6,259.58) | (5,516.86) | (5,556.48) | (5,133.82) | (5,061.97) | (4,891.29) | (4,831.27) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 19.65 | 0.00 | 33.02 | 0.00 | 183.19 |
Capex to Sales |
— | 0.06 | 0.07 | 0.08 | 0.08 | 0.08 | 0.11 | 0.13 | 0.13 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 7.47 | 0.00 | 5.46 | 0.00 | 24.43 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.00 | 2.24 | 2.15 | 1.99 | 1.83 | 1.63 | 1.53 | 1.39 |
Cash ROIC |
— | 0.00% | 2.94% | 4.22% | 4.31% | 4.10% | 0.99% | (0.23%) | (0.28%) |
Accounts Receivable Turnover |
— | 0.00 | 14.04 | 13.37 | 13.70 | 12.08 | 12.37 | 11.19 | 8.88 |
Accounts Payable Turnover |
— | 0.00 | 11.97 | 25.67 | 12.40 | 15.52 | 14.32 | 4.52 | 3.45 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 0.00 | 23.34 | 17.48 | 27.08 | 23.78 | 30.37 | 131.62 | 87.09 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 70.00 | 70.13 | 81.55 | 89.41 | 77.73 | 83.16 | 108.69 |
Average Payables |
— | — | 12.50 | 12.41 | 14.13 | 13.15 | 16.44 | 52.96 | 73.40 |
Average Assets |
— | 0.00 | 4,180.21 | 8,321.99 | 8,251.99 | 7,795.76 | 7,167.90 | 6,057.76 | 5,019.64 |
Average Common Equity |
— | — | 2,271.50 | 2,271.54 | 2,451.27 | 2,067.61 | 1,749.83 | 896.57 | (41.58) |
Columns are period end dates